Novo CEO, in bidding war with Pfizer, says Metsera’s drugs would complement pipeline Novo Nordisk is trying to regain its footing in the increasingly competitive obesity drug market

https://www.statnews.com/2025/11/05/novo-nordisk-metsera-mike-doustdar-pfizer-bidding-war/